about
ABL1 BCR-ABL T315IABL1 BCR-ABL E255KABL1 BCR-ABL F317LKIT D816VABL1 BCR-ABL F359VABL1 BCR-ABL M244VABL1 BCR-ABL L248VABL1 BCR-ABL G250EABL1 BCR-ABL Q252HABL1 BCR-ABL Y253HABL1 BCR-ABL D276GABL1 BCR-ABL M351TABL1 BCR-ABL H396RABL1 BCR-ABL F486SABL1 BCR-ABL E255VABL1 BCR-ABL F359CABL1 BCR-ABL L384MABL1 BCR-ABL V299LABL1 BCR-ABL E355GABL1 BCR-ABL L387MABL1 BCR-ABL F359IABL1 BCR-ABL F317VABL1 E279KABL1 BCR-ABL V379IABL1 BCR-ABL A397PABL1 BCR-ABL F317IABL1 BCR-ABL T315AABL1 BCR-ABL L248RABL1 BCR-ABL F317SABL1 BCR-ABL F317CABL1 BCR-ABL E459KABL1 TKD MUTATIONABL1 BCR-ABL D363GABL1 BCR-ABL E98GABL1 BCR-ABL E450Q
P3355
P3781
Dasatinib: an anti-tumour agent via Src inhibition.Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
P921
Q27653851-07085540-6F5F-4CEA-9A9F-18F8518CEC5AQ27653851-9F4F3F5B-2D79-41AD-8588-F4DD99BD7B9FQ27653851-DD4FCFC0-C7E7-4E72-BC8B-13E1EC8C62CFQ28370999-E55C5325-3883-4A2E-892C-0113158372F9Q28371006-4FA34C47-A260-4E13-9307-601851AD185EQ28371006-E261B1DF-52E4-4443-AC5D-D43C4B90717BQ28371006-F9864130-B9DD-4AEC-B817-3E25D0A223AAQ28371058-7966FEC0-85F9-4520-B858-BFF2AC408014Q28371059-644D6980-77C4-4A80-91EC-E6DEFFFE3493Q28371060-42307BCB-E454-4557-A815-FB222F76F49EQ28371061-209C9584-4B7D-4DFB-BA96-59ECA3BCC9DBQ28371062-8E03BE73-E645-48BC-BA2F-F79737E810FAQ28371063-D5F34333-E381-4872-962A-12FDEB1505F5Q29938719-6FC5C506-A950-4DC3-8E21-A599624556DFQ29938805-2D2AC8F0-FC46-40F7-80A5-2CBF19B791F6Q32965503-633618DD-06AC-484C-8868-2E67B8D6A6D6Q32965507-51F77539-2969-427D-BFE8-FE492EAC5E4EQ32965517-EC174687-45C1-4FB0-B98B-647A7935CD4FQ79419380-DBCF0208-8891-4B53-9F1F-51AFA8FA10B0Q83482777-9C9C9D90-0C38-4350-88E3-4635CA0482DB
P3354
Q27906612-1E7D0C19-9E5A-4B08-AAB0-1023F16B767EQ27906612-28E383AB-8201-4A5F-8732-AE7C6D4F8AECQ27906612-B35B054F-1F44-4C1C-9C99-6BFEF14DFA51Q27906612-D6E1728C-3284-49F5-A8B0-3C3C66AFBD37Q27906817-22BB749F-3091-4064-9B09-0DE3F42340EAQ27906817-5AE5F521-1E74-4423-9E7C-A9D1AAF85856Q27906817-60E8DC07-454B-4346-9BEA-318AA8DEE05BQ27906817-726ABF8A-DA30-41C8-AC60-B53B138C6668Q27906817-E578DD97-441D-4679-88A1-35CBCCBA2EE7Q28371204-129D2CE6-B0D7-4E6E-B5DE-5428751EB9AAQ28371204-23F8BF03-CE5B-4966-A9C1-226ECA448D07Q28371204-26874469-F2AD-446D-B0F7-937B61E0F2BBQ28371204-CBF767BD-5092-4034-B610-F2739288468EQ28531481-5327F5AD-E7EA-4FC8-89F1-377C669A398DQ29938345-3E4DA9F3-D308-4D83-8B25-35C0EDD78EE5Q29938345-83B391EC-B76E-4388-A9B9-0C5B11E67384Q29938345-FC021C82-09A9-4BF7-B269-9AF5473288BEQ29938509-12773E05-079D-4F49-9CCF-B2E24989F96DQ29938509-7DCCBD48-B73C-49A5-B467-7FA71A9184AAQ29938511-11CD9056-4A1E-4947-95A2-BF33C6BCF5BFQ29938511-D39D349D-DB14-4F00-AF3F-0DA37FC0C776Q29938513-33DD9109-AE51-4EFC-9CC2-F2124DF7C236Q29938514-3EAB6D53-BE66-4AFF-AE00-90149F698D55Q29938514-6A2F8731-0471-4C4E-9B57-2AFF8C11A9D3Q29938514-DF8248C4-7C19-484C-9933-1815BBDBC883Q29938515-46D6E774-CCDC-4F9D-B2C2-F8A0F0146AB4Q29938518-B4BD099E-6CA3-4457-8556-A418383ED9FCQ29938520-0182574A-8D45-4AC9-9C0B-05B0561F2D2EQ29938523-0287B4EB-CC3A-4FF0-93FD-290B1D1C6E8FQ29938523-F8EDCBF2-FD63-4632-81F3-950C06E01737Q29938666-CEAB3204-EABB-4A73-88B0-F2B560333951Q29938702-31AFD96B-9F99-4E73-90F1-AF0FEF0301E2Q29938702-B2AB518A-CA35-494E-AB01-6ED9403FDCA3Q29938707-0991F348-4F1D-416F-B0E2-292B04B014FBQ29938707-45809FCB-DA14-41EE-8E62-BE65BC1CC504Q29938707-4944E6B3-8BB7-4F4D-BAB3-58CABAC5E7A7Q29938714-84736C95-C0F9-4617-9512-6D242E399B50Q29938716-46C8F62C-8AC2-44C2-A3CA-C8B6A4E130ADQ29938716-AC046F7E-1F56-4991-A75E-EC1B138FA912Q29938716-C7FC62F4-9676-46A5-83BE-67BB247BAC30
P3355
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
dasatinib monohydrate
@en
dasatinib monohydraté
@fr
dasatinibmonohydrat
@nn
type
label
dasatinib monohydrate
@en
dasatinib monohydraté
@fr
dasatinibmonohydrat
@nn
altLabel
BMS 354825-03
@en
BMS 35482503
@en
N-(2-chloro-6-methylphenyl)-2- ...... thiazole-5-carboxamide hydrate
@en
dasatinib hydrate
@en
dasatinib
@en
dasatinib.H2O
@en
prefLabel
dasatinib monohydrate
@en
dasatinib monohydraté
@fr
dasatinibmonohydrat
@nn
P2175
P672
P486
P661
P662
P665
P683
P1579
P1748
P2017
O.CC1=NC(NC2=NC=C(S2)C(=O)NC3=C(C)C=CC=C3Cl)=CC(=N1)N4CCN(CCO)CC4
P2067
505.166286
P2175
P231
863127-77-9
P232
P233
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C.O
P234
1S/C22H26ClN7O2S.H2O/c1-14-4-3 ...... 3,(H,28,32)(H,24,25,26,27);1H2
P235
XHXFZZNHDVTMLI-UHFFFAOYSA-N
P2566
100.166.542
P274
C₂₂H₂₈ClN₇O₃S